Mohan Iyer
General Partner @ SOSV
San Francisco, United States
Mohan Iyer is a seed investor at SOSV in San Francisco focused on Biotechnology and Health Care. Mohan Iyer is the Partner at IndieBio. Mohan Iyer attended Yale School of Management.
- Total investments:
- 32
- Last investment:
- Lead investor:
- 53%
Last updated:
For AI agents: llms.txt
Industries Mohan Iyer invests in
Stages Mohan Iyer invests in
Countries Mohan Iyer invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 11 (34%)
- Health Care 8 (25%)
- Life Science 5 (16%)
- Energy 3 (9%)
- Medical 3 (9%)
Stage
- Seed 23 (72%)
- Pre-Seed 2 (6%)
- Convertible Note 2 (6%)
- Series A 1 (3%)
Country
- United States 17 (53%)
- United Kingdom 2 (6%)
- Canada 1 (3%)
- Israel 1 (3%)
- Uruguay 1 (3%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Fermeate provides photomolecular fermentation technology to increase sustainability and efficiency in the biomanufacturing industry. | $2.5M / Seed / Apr 27, 2026 | ||
| Antarka develops Antarctic-derived enzymes that repair UV-damaged skin DNA, powering next-generation anti-aging and skin health solutions. | Seed / Feb 09, 2026 | ||
| Endaris is a climate technology product manufacturing company that provides industrial catalytic converters to eliminate methane emissions. | Seed / Feb 09, 2026 | ||
| Transition Biomining is a metal ore mining technology company that offers data driven solutions for copper extraction and mining. | $6M / Seed / Jan 15, 2026 | ||
| DisperseBio is a Biotechnology Research firm developing a mechanism to counter microbial contamination on natural surfaces like human body. | Seed / Jan 14, 2026 | ||
| Cellens is a medical device company that provides clarity and focus on cancer detection. Cellens is a Tufts University spinoff company dedicated to providing patients and doctors with clarity and confidence through noninvasive cancer screening. It was founded in 2019 and is based in Medford, Massachusetts. | $6.5M / Seed / Dec 23, 2025 | ||
| We're developing personalized assays to determine the most suitable medication for cancer therapy at the patient level. Through our proprietary Drug Activity and Resistance Test, oncologists will be able to make data-driven decisions regarding cancer therapy selection based on patient-derived samples. Our goal is to democratize access toPrecision Oncology and improve cancer patients' lives. | $4.5M / Seed / Nov 24, 2025 | ||
| FLOUV is a tech company that specialises in non-thermal UV-C processing for opaque and viscous liquids, delivering microbial inactivation. | Seed / Aug 18, 2025 | ||
| Augment Biologics focuses on transforming the design and engineering of biologic drugs by precisely controlling glycosylation. | Seed / Aug 13, 2025 | ||
| ReefStarter designs modular reef-like systems to protect coastlines, reduce waves, and support marine life. | Seed / Aug 11, 2025 | ||
| See all 32 investments → | |||
Co-Investors
About SOSV
SOSV is a global venture capital firm that focuses on deep tech investments through the HAX and IndieBio startup development programs aimed at human and planetary health. The firm invests in startups at their inception, providing support to accelerate their next institutional funding round. HAX offers facilities and engineering resources, whileIndieBio provides services and lab equipment for founders. The firm targets deep technology innovations in the health and environmental sectors.
SOSV Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Arvind Gupta
General Partner
|
|||
Blaine Doyle
Mentor
|
|||
Cyril Ebersweiler
General Partner
|
|||
Deborah Zajac
General Partner
|
|||
Duncan Turner
General Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Mohan Iyer invest in?
Mohan Iyer invests primarily in Biotechnology, Health Care and Life Science startups, most often at Seed and Pre-Seed stage. Most of the 32 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Mohan Iyer?
Public channels for Mohan Iyer include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Mohan Iyer last invest?
The most recent investment recorded for Mohan Iyer closed in Apr 2026. Shizune tracks 32 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
